Dolomite Bio introduces high throughput sNuc-Seq protocol for its Nadia Instrument

Dolomite Bio, a leading provider of single-cell technology, today launched a high throughput single nuclei RNA sequencing (sNuc-Seq) protocol for its Nadia Instrument. This latest addition to the Nadia application portfolio enables researchers to cost-effectively profile both complex and archived tissues with the goal of accelerating disease and drug discovery research in areas such as oncology and neurology. The new application is being introduced at the Single Cell Analysis Congress in London on the 8th and 9th of November 2018.

Featuring a tailored protocol for nuclei preparation based on the work of Habib et al, the new application enables researchers to consistently and reproducibly capture high numbers of genes at low doublet rates and minimal cost. Detailed information and example data can be downloaded at www.dolomite-bio.com/single-nuclei-rna-seq-nadia

Heike Fiegler, VP of Biology Products at Blacktrace Holdings Ltd, said:

We are delighted to launch sNuc-Seq for Nadia users, which is an important step forward for the single-cell community. The new application has significant potential to accelerate disease research into complex tissues, overcoming the problems previously encountered in gene expression profiling of single cells in archived tissues or cells that are generally difficult to isolate.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Dolomite Bio develops novel tools throughout 2018 and shows continued growth